{"public_id":"co_5c4a7ee502eb80de5f9d9b4a0154e0c1","status":"active","merged_into_public_id":null,"resolved_public_id":"co_5c4a7ee502eb80de5f9d9b4a0154e0c1","name":"RNA viruses","description":"Viruses whose genetic material is RNA.","aliases":[],"types":["virus class"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":583709,"title":"Interferons at age 50: past, current and future impact on biomedicine","citation_count":1171,"url":"https://sah.borca.ai/papers/583709"}],"claims":[{"public_id":"cl_e5fcf6095b74fb97a673d8419564d3c3","text":"Interferons have clinical effectiveness against both RNA and DNA viruses.","corpus_id":583709,"url":"https://sah.borca.ai/claims/cl_e5fcf6095b74fb97a673d8419564d3c3"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_5c4a7ee502eb80de5f9d9b4a0154e0c1","url":"https://sah.borca.ai/concepts/co_5c4a7ee502eb80de5f9d9b4a0154e0c1"}